Betűméret: A A A

Gyógyszer vizsgálatok

Néhány vizsgálat az elmúlt évekből:

2011, fázis III., Effect of strontium ranelate (2g per day) in the management of limb fractures with delayed-union or non union: an international open label study in patients with osteoporosis CL3-12911-036

2011, fázis III., Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy AMG 073 20070277

2010, fázis II., NBI-56418-0703 Efficacy and Safety Study in Endometriosis With NBI-56418; Placebo and Active Controlled

2010, fázis III., Efficacy and safety of strontium ranelate/vitamin D3 combination on vitamin D insufficiency in the treatment of osteoporotic patient CL3-06911-002

2009, post marketing study, Xarelto in the prophylaxis of post surgical venous thromboembolism after elective major orthopaedic surgery of the hip or knee.

2008, fázis III., A two year multicenter, randomised, double-blind, placebo controlled, paralell group study to evaluete the farcture efficacy and safety of intravenous zolendronic acid 5mg annually for the treatment of osteoporosis in men CZOL446M2309

2007/2009, fázis II., Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis. OCEAN Study ONO-5334POE003

2007/2009, fázis III., A double-blind, multicentre, international randomised study to assess the effects of 6 months or 12 months administration of strontium ranelate versus biphosphonates on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosis. CL3-12911-025

2007/2008, fázis II., Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis 07-IAT-0171/CS82-000-04

2006, fázis III., A randomised, open label, multinational, multicenter study to investigate the impact of bone marker feedback on adherence to once monthly ibandronate treatment of patients with PMOP supported by PRP

2006, fázis III., Analgesic efficacy and safety of intravenous Paracetamol 1 % solution Bioren, Perfalgic and placebo in a post surgical total hip replacement model.

2006/2007, fázis III., RECORD 1 trial, Rivaroxaban the prophylaxis of post surgical venous thromboembolism after elective total hip arthroplasty.

2003, fázis II., CASPI-study,térd osteoarthritis MMPI kezelése, 39 beteg

2000-2002, fázis III., Osteoporosis prevention in postmenopausal women with S21400 ( intranasal 17 -estradiol ) : long term treatment Study No: CL3-21400-017

1999-2000, fázis III., Efficacy of continuos opposed hormone replacement therapy using Aerodiol (intranasal 17 -estradiol 150 or 300 g/day ) , for prevention of bone loss in postmenopausal women Study No: CL3-21400-010